CorMedix Inc
NASDAQ:CRMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CorMedix Inc
NASDAQ:CRMD
|
US |
|
E
|
Experian PLC
DUS:J2B
|
IE |
Intrinsic Value
The intrinsic value of CorMedix Inc (CRMD) under the Base Case is 20.332 USD per share.
Compared with the current market price of 5.285 USD, the stock appears
Undervalued by 74% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What CorMedix Does
CorMedix is a biopharmaceutical company focused on reducing infections tied to medical devices. Its main product is a catheter lock solution used inside central venous catheters to help prevent serious bloodstream infections, especially in patients who rely on long-term vascular access such as hemodialysis patients. In simple terms, the company sells a drug product designed to sit in the catheter when it is not in use and lower the chance that bacteria will grow there.
- Headquarters
- United States of America US
- Employees
- 191
- IPO date
- Mar 25, 2010
CorMedix has a narrow economic moat
CorMedix Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
CorMedix Inc
Earnings Waterfall
CorMedix Inc
The intrinsic value for CorMedix Inc (CRMD) under the Base Case is 20.332 USD.
Compared with the current market price of 5.285 USD, the stock appears Undervalued by 74% .
